Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.50p
   
  • Change Today:
    -0.100p
  • 52 Week High: 5.34p
  • 52 Week Low: 2.25p
  • Currency: UK Pounds
  • Shares Issued: 1,041.69m
  • Volume: 952,478
  • Market Cap: £46.88m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 10.39 (1.89) (1.89)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.52 (19.91) (10.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 5.50 (49.43) (21.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 13.09 (32.38) (5.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 32.18 (26.56) (3.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 39.79 (7.97) (47.92)p n/a n/a n/a n/a 0.0%
31-Dec-26 60.40 0.67 9.45p 0.5 n/a n/a n/a 0.0%
31-Dec-27 91.90 17.60 1.56p 2.9 n/a -84% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

STX Market Data

Currency UK Pounds
Share Price 4.50p
Change Today -0.100p
% Change -2.17 %
52 Week High 5.34p
52 Week Low 2.25p
Volume 952,478
Shares Issued 1,041.69m
Market Cap £46.88m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.5% below the market average12.5% below the market average12.5% below the market average12.5% below the market average12.5% below the market average
67.44% above the sector average67.44% above the sector average67.44% above the sector average67.44% above the sector average67.44% above the sector average
Price Trend
32.78% above the market average32.78% above the market average32.78% above the market average32.78% above the market average32.78% above the market average
15.56% below the sector average15.56% below the sector average15.56% below the sector average15.56% below the sector average15.56% below the sector average
Income Not Available
Growth
63.46% above the market average63.46% above the market average63.46% above the market average63.46% above the market average63.46% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
16:35 500 @ 4.50p
16:35 500 @ 4.50p
15:06 4,000 @ 4.72p
13:23 216,569 @ 4.62p
11:21 10,000 @ 4.75p

STX Key Personnel

CEO Anders Lundstrom

Top of Page